Biblio

] Title Type Year

Filters: First Letter Of Last Name is N [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

N

Najahi H, Alessio N, Squillaro T, Conti GOliveri, Ferrante M, Di Bernardo G, Galderisi U, Messaoudi I, Minucci S, Banni M. Environmental microplastics (EMPs) exposure alter the differentiation potential of mesenchymal stromal cells. Environ Res. 2022:114088.

Najar AH, Sneha KM, Ashok A, Babu S, Subramaniam AG, Kannan R, Viswanath B, Purushottam M, Varghese M, Parvez S, et al. Derivation of iPSC lines from two patients with familial Alzheimer's disease from India. Stem Cell Res. 2018;34:101370.

Najar M, Lombard CA, Fayyad-Kazan H, Faour WH, Merimi M, Sokal EM, Lagneaux L, Fahmi H. Th17 immune response to adipose tissue-derived mesenchymal stromal cells. J Cell Physiol. 2019.

Najar M, Bouhtit F, Rahmani S, Bouali A, Melki R, Najimi M, Lewalle P, Merimi M. The immunogenic profile and immunomodulatory function of mesenchymal stromal / stem cells in the presence of Ptychotis verticillata. Heliyon. 2024;10(3):e24822.

Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, Lagneaux L. Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis. Stem Cell Rev. 2014.

Najas S, Arranz J, Lochhead PA, Ashford AL, Oxley D, Delabar JM, Cook SJ, Barallobre MJosé, Arbonés ML. DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome. EBioMedicine. 2015;2(2):120-134.

Najera J, Hao J. Recent advance in mesenchymal stem cells therapy for atopic dermatitis. J Cell Biochem. 2022.

Najima Y. Overcoming relapse: prophylactic or pre-emptive use of azacitidine or FLT3 inhibitors after allogeneic transplantation for AML or MDS. Int J Hematol. 2023.

Najima Y, Tomizawa-Murasawa M, Saito Y, Watanabe T, Ono R, Ochi T, Suzuki N, Fujiwara H, Ohara O, Shultz LD, et al. Induction of WT1 specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/Il2rgKO mice. Blood. 2015.

Najjar RP, Wolf L, Taillard J, Schlangen LJM, Salam A, Cajochen C, Gronfier C. Chronic Artificial Blue-Enriched White Light Is an Effective Countermeasure to Delayed Circadian Phase and Neurobehavioral Decrements. PLoS One. 2014;9(7):e102827.

Najm R, Zalocusky KA, Zilberter M, Yoon SYeon, Hao Y, Koutsodendris N, Nelson M, Rao A, Taubes A, Jones EA, et al. In Vivo Chimeric Alzheimer's Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons. Cell Rep. 2020;32(4):107962.

Najmi Z, Mlinarić NMatijakovi, Scalia ACalogero, Cochis A, Selmani A, Učakar A, Abram A, Zore A, Delač I, Jerman I, et al. Antibacterial evaluation of different prosthetic liner textiles coated by CuO nanoparticles. Heliyon. 2024;10(1):e23849.

Naka K, Ishihara K, Jomen Y, Jin CHua, Kim D-H, Gu Y-K, Jeong E-S, Li S, Krause DS, Kim D-W, et al. The novel oral TGF-β signaling inhibitor EW-7197 eradicates chronic myelogenous leukemia-initiating cells. Cancer Sci. 2015.

Naka-Kaneda H, Nakamura S, Igarashi M, Aoi H, Kanki H, Tsuyama J, Tsutsumi S, Aburatani H, Shimazaki T, Okano H. The miR-17/106-p38 axis is a key regulator of the neurogenic-to-gliogenic transition in developing neural stem/progenitor cells. Proc Natl Acad Sci U S A. 2014;111(4):1604-9.

Nakada D. Venetolax with Azacitidine Drains Fuel from AML Stem Cells. Cell Stem Cell. 2019;24(1):7-8.

Nakadai T, Shimada M, Ito K, Cevher MAlper, Chu C-S, Kumegawa K, Maruyama R, Malik S, Roeder RG. Two target gene activation pathways for orphan ERR nuclear receptors. Cell Res. 2023.

Nakade K, Tsukamoto S, Nakashima K, An Y, Sato I, Li J, Shimoda Y, Hemmi Y, Miwa Y, Hayashi Y. Efficient selection of knocked-in pluripotent stem cells using a dual cassette cellular elimination system. Cell Rep Methods. 2023:100662.

Nakafuku M, Del Águila Á. Developmental dynamics of neurogenesis and gliogenesis in the postnatal mammalian brain in health and disease: Historical and future perspectives. Wiley Interdiscip Rev Dev Biol. 2019:e369.

Nakagaki S, Arimura Y, Nagaishi K, Isshiki H, Nasuno M, Watanabe S, Idogawa M, Yamashita K, Naishiro Y, Adachi Y, et al. Contextual niche signals towards colorectal tumor progression by mesenchymal stem cell in the mouse xenograft model. J Gastroenterol. 2015.

Nakagaki M, Gavin NC, Hayes T, Fichera R, Stewart C, Naumann L, Brennan J, Perry N, Foley E, Crofton E, et al. Implementation and evaluation of a nurse-allied health clinic for patients after haematopoietic stem cell transplantation. Support Care Cancer. 2021.

Nakagami T, Tawara Y, Arizono S, Shinya J, Naito K. A Comparison of the Physical Activity and Sedentary Behavior between Autologous and Allogeneic Hematopoietic Stem Cell Transplantation Survivors. Intern Med. 2023.

Nakagawa MMarshall, Rathinam CVendan. Constitutive Activation of the Canonical NF-κB Pathway Leads to Bone Marrow Failure and Induction of Erythroid Signature in Hematopoietic Stem Cells. Cell Rep. 2018;25(8):2094-2109.e4.

Nakagawa Y, Yamada S. A novel hypothesis on metal dyshomeostasis and mitochondrial dysfunction in amyotrophic lateral sclerosis: Potential pathogenetic mechanism and therapeutic implications. Eur J Pharmacol. 2020:173737.

Nakagawa S, Ando W, Shimomura K, Hart DA, Hanai H, Jacob G, Chijimatsu R, Yarimitu S, Fujie H, Okada S, et al. Repair of osteochondral defects: efficacy of a tissue-engineered hybrid implant containing both human MSC and human iPSC-cartilaginous particles. NPJ Regen Med. 2023;8(1):59.

Nakagawa Y, Yamada S. Metal homeostasis disturbances in neurodegenerative disorders, with special emphasis on Creutzfeldt-Jakob disease - Potential pathogenetic mechanism and therapeutic implications. Pharmacol Ther. 2019:107455.

Pages